is

Eisai withdraws weight loss pills because of cancer risk




is

N<sub>2</sub>O no laughing matter for Lonza in Visp




is

Sabic to shutter Spanish polyether imide capacity




is

Women publish at rates equal to men but leave science earlier




is

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms previous concerns about health effects of chlorinated solvent




is

Chemistry in Pictures: Tinsel town




is

China's new place on the front lines of diagnosing and treating coronavirus disease

Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak




is

Simple synthesis for shapeshifting molecules

Bullvalene's constant metamorphosis could be exploited in sensing applications




is

Beryllium radical cation isolated

First Be(I) compounds to be crystallized could open up new main group chemistry




is

Chemistry in Pictures: Crystals from outer space




is

Thermo Fisher to buy molecular diagnostics firm Qiagen for $11.5 billion

Purchase brings the instrumentation giant into the fight against coronavirus




is

US EPA finalizes list of 20 low-priority chemicals

Substances will not undergo further evaluation of health and safety risks at this time




is

Trichloroethylene poses risks to workers and consumers, EPA says

Draft assessment confirms concerns about health effects of chlorinated solvent




is

Simple synthesis for shape-shifting molecules

Bullvalene's constant metamorphosis could be exploited in sensing applications




is

Limiting global warming is getting harder, analysis says

Without policy changes, the gap between actual greenhouse gas emission reductions and those needed to hit climate targets will continue to widen




is

Chemistry in Pictures: Silver whiskers




is

ACS Strategic Plan highlights recent accomplishments




is

First in vivo CRISPR gene editing in humans




is

Lilac Solutions raises funds for new lithium extraction method




is

C16 raises funds for palm oil fermentation




is

Calysta and Adisseo plan fish feed venture in Asia




is

Orionis Biosciences launches with Novartis pact




is

Scientists' favorite DIY lab equipment, and making lab trash live on




is

Beryllium radical cation isolated

First Be(I) compounds to be crystallized could open up new main-group chemistry




is

Cristina Sáenz de Pipaón wants to put CO<sub>2</sub> to good use

Her company, Orchestra Scientific, is developing membrane technology to separate carbon dioxide from other gases and use it as a product




is

Amy Ripka on being a CEO: ‘Nobody ever got anywhere by listening to no'

Lucy Therapeutics founder is taking an atypical approach to finding drugs for central nervous system diseases




is

Sarah Richardson on prestige publishing: ‘Luckily, I don't give a crap about that'

Her company, MicroByre, is proving that wild microbes can be engineered to produce useful chemicals




is

Amy Prieto is building safer, more powerful batteries

With Prieto Battery, the Colorado State professor has redesigned the lithium-ion battery from the bottom up




is

Erika Milczek is replacing banned chemicals in consumer products

With Curie Co., the entrepreneur designs alternatives to compounds like parabens that have fallen out of favor with retailers




is

Olga Malinkiewicz wants to make good on the promise of perovskites

Her company, Saule Technologies, has a low-cost process to print the solar cells on a multitude of materials




is

Yamuna Krishnan's goal: Find drugs for neurodegenerative diseases

Her company, Esya Labs, is developing DNA nanodevices that track drug responses, screen for new therapies, and more




is

Naomi Halas on being a scientist: ‘We need to be attracted to the big, hard problems'

Nanotech pioneer aims to pursue grand challenges rather than just write about them




is

Frances Arnold on founding a company: ‘Building the right teams is critical'

Nobel Prize winner wants to solve real-world problems with directed evolution




is

A day with Jennifer Doudna: Trying to keep up with one of the world's most sought-after scientists

The gene-editing tool CRISPR-Cas9 rerouted Doudna's career path. What hasn't changed for the renowned scientist and serial entrepreneur? Living and breathing the science




is

CRISPR technology: Where female entrepreneurs thrive

Dozens of women lead CRISPR-based projects worldwide. Here are a few who've built start-ups around the technology




is

C&EN's 2020 Trailblazers: Celebrating badass women entrepreneurs in chemistry

With guest editor Jennifer Doudna, CRISPR pioneer




is

C&EN's Chemistry in Pictures goes meta

Our collection of chemistry photos will help train an algorithm to recognize lab materials, vessels, and processes




is

Chemists work around coronavirus restrictions

C&EN looks at how scientists are adapting to travel restrictions and working from home




is

Podcast: How the coronavirus could disrupt the drug supply

Hear what C&EN's pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe




is

Chemistry in Pictures: Baby Yodamine B




is

Merck and Princeton scientists create method to map cell-surface microenvironments

The technique, called MicroMapping, identifies potential protein interactions on and between cells




is

Chemistry in Pictures: Big swirl




is

Chemistry in Pictures: Be still, my giant rotovap




is

How COVID-19 is changing my graduate school experience




is

How we know disinfectants should kill the COVID-19 coronavirus

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking




is

AI specialist Atomwise signs with Bridge Biotherapeutics




is

Culture Biosciences raises $15 million for bioreactor service




is

Protein degradation start-up Kymera raises $102 million in series C financing




is

OMV to raise stake in Borealis




is

Chemists work around coronavirus restrictions

C&EN looks at how scientists are working from home and adapting to travel restrictions